A. Jayol
Clinical Microbiology Reviews · 2017
A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Whom A. Jayol trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from A. Jayol's perspective
Ordered by how strongly the researchers A. Jayol trusts endorse each paper. Same corpus, a different order for every researcher.
- Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. (Clinical Infectious Diseases)
- Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. (Lancet. Infectious Diseases (Print))
- Toxicity of polymyxins: a systematic review of the evidence from old and recent studies (Critical Care)
- The Pleiotropic Two-Component Regulatory System PhoP-PhoQ (Journal of Bacteriology)
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. (Lancet. Infectious Diseases (Print))
- Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production (Antimicrobial Agents and Chemotherapy)
- Challenges and Potential Solutions – Individualised Antibiotic Dosing at the Bedside for Critically Ill Patients: a structured review (Lancet. Infectious Diseases (Print))
- Antimicrobial susceptibility testing: a review of general principles and contemporary practices. (Clinical Infectious Diseases)
- Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. (Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin)
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. (Clinical Microbiology and Infection)